Cathie Wood, the founder of Ark Invest, has become a legend for her bold investments in transformative tech. With a keen eye for the next big thing, Wood’s portfolio is focused on companies that target disruptive innovation, spanning genomics, artificial intelligence (AI), and fintech. Her moves are closely watched by investors eager to catch her latest picks.
The genomics market is set to hit $411.35 billion by 2031, expanding at a CAGR of 19.4%, thanks to the groundbreaking discoveries and next-generation sequencing innovations. 10x Genomics, Inc. (TXG), a pioneering life sciences company that’s revolutionizing the field of genomics, is one of the biotech names that’s capturing Wood’s attention. Despite recent volatility in TXG stock, Wood’s enthusiasm hasn’t waned. She is grabbing the shares, and betting big on the company’s role in revolutionizing genomics.
